Cannabidiols, or CBDs
Offering a variety of products, from ointments to combustibles and hemp, CBD companies are going to be in full force at TPE. Demand is only growing for these medicinal remedies—a projected $22 billion business by 2022—that have little to none of the psychoactive chemicals found in marijuana, according to Rolling Stone.
With the passage late last year of the Farm Bill, include hemp in that growing industry, because the Agriculture Improvement Act of 2018 brought hemp from being a Schedule 1 drug (regulated on the level of heroin) to a Schedule 5, which compares to cough medicine. Industry observers believe the number of products in the hemp subcategory will only increase.